Home   Chapter Home   Jobs   Conferences   Fellowships   Books



Advertisement

Kidney non-tumor

Kidney transplantation

Kidney transplantation-general


Reviewers: Nikhil Sangle, M.D. (see Reviewers page)
Revised: 26 December 2012, last major update August 2012
Copyright: (c) 2003-2012, PathologyOutlines.com, Inc.

Biopsies
=========================================================================

Determine
● (a) if graft failure is due to acute tubular necrosis, drug related nephrotoxicity (cyclosporin, tacrolimus), infections, outflow tract obstruction, primary glomerular disease, rejection, vascular obstruction
● (b) for rejection, intensity and nature, potential reversibility and thus most suitable therapy

Clinical features
=========================================================================

● First transplant performed in 1950 (Wikipedia)
● Better prognosis with living donors and younger donors (Transpl Int 2012;25:1150)
● ABO-incompatible kidney transplantation is effective (Transplant Rev (Orlando) 2012 Aug 14 [Epub ahead of print])
● Mismatches for HLA class II were more strongly associated with hospitalization and death with functionng graft than mismatches for HLA class I.(Am J Transplant 2012 Aug 17 [Epub ahead of print])

Gross images
=========================================================================



Kidney transplant

Micro images
=========================================================================



Post-transplant biopsies

End of Kidney non-tumor > Kidney transplantation > Kidney transplantation-general

Ref Updated: 8/28/12


This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.

All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).